Global Opioid Induced Constipation (OIC) Drug Market Insights, Forecast to 2025
- QYR2792375
- 125 Pages
- October 2018
- Pharmaceuticals
In 2017, the global Opioid Induced Constipation (OIC) Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Opioid Induced Constipation (OIC) Drug market based on company, product type, application and key regions.
This report studies the global market size of Opioid Induced Constipation (OIC) Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Opioid Induced Constipation (OIC) Drug in these regions.
This research report categorizes the global Opioid Induced Constipation (OIC) Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
The various contributors involved in the value chain of Opioid Induced Constipation (OIC) Drug include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Opioid Induced Constipation (OIC) Drug include
Ironwood Pharmaceuticals
Daiichi Sankyo Co
Pfizer
Progenics Pharmaceuticals
Shionogi &
Allergan
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma
Mundipharma International Limited
Ono Pharmaceutical
Takeda Pharmaceutical Company Limited
Theravance Biopharma
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Market Size Split by Type
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
Market Size Split by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Opioid Induced Constipation (OIC) Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Opioid Induced Constipation (OIC) Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Opioid Induced Constipation (OIC) Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Opioid Induced Constipation (OIC) Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Opioid Induced Constipation (OIC) Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Opioid Induced Constipation (OIC) Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Opioid Induced Constipation (OIC) Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Opioid Induced Constipation (OIC) Drug Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type
1.4.2 Lubiprostone
1.4.3 Methyl Naltrexone Bromide
1.4.4 Naldemedine
1.4.5 Alvimopan
1.4.6 Other
1.5 Market by Application
1.5.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Opioid Induced Constipation (OIC) Drug Market Size
2.1.1 Global Opioid Induced Constipation (OIC) Drug Revenue 2016-2025
2.1.2 Global Opioid Induced Constipation (OIC) Drug Sales 2016-2025
2.2 Opioid Induced Constipation (OIC) Drug Growth Rate by Regions
2.2.1 Global Opioid Induced Constipation (OIC) Drug Sales by Regions
2.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers
3.1.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers
3.1.2 Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers
3.1.3 Global Opioid Induced Constipation (OIC) Drug Market Concentration Ratio (CR5 and HHI)
3.2 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers
3.2.1 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2016-2018)
3.2.2 Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2016-2018)
3.3 Opioid Induced Constipation (OIC) Drug Price by Manufacturers
3.4 Opioid Induced Constipation (OIC) Drug Manufacturing Base Distribution, Product Types
3.4.1 Opioid Induced Constipation (OIC) Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Opioid Induced Constipation (OIC) Drug Product Category
3.4.3 Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Opioid Induced Constipation (OIC) Drug Sales by Type
4.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Type
4.3 Opioid Induced Constipation (OIC) Drug Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Opioid Induced Constipation (OIC) Drug Breakdown Data by Application
6 North America
6.1 North America Opioid Induced Constipation (OIC) Drug by Countries
6.1.1 North America Opioid Induced Constipation (OIC) Drug Sales by Countries
6.1.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Opioid Induced Constipation (OIC) Drug by Type
6.3 North America Opioid Induced Constipation (OIC) Drug by Application
6.4 North America Opioid Induced Constipation (OIC) Drug by Company
7 Europe
7.1 Europe Opioid Induced Constipation (OIC) Drug by Countries
7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Countries
7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Opioid Induced Constipation (OIC) Drug by Type
7.3 Europe Opioid Induced Constipation (OIC) Drug by Application
7.4 Europe Opioid Induced Constipation (OIC) Drug by Company
8 Asia Pacific
8.1 Asia Pacific Opioid Induced Constipation (OIC) Drug by Countries
8.1.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Countries
8.1.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Opioid Induced Constipation (OIC) Drug by Type
8.3 Asia Pacific Opioid Induced Constipation (OIC) Drug by Application
8.4 Asia Pacific Opioid Induced Constipation (OIC) Drug by Company
9 Central & South America
9.1 Central & South America Opioid Induced Constipation (OIC) Drug by Countries
9.1.1 Central & South America Opioid Induced Constipation (OIC) Drug Sales by Countries
9.1.2 Central & South America Opioid Induced Constipation (OIC) Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Opioid Induced Constipation (OIC) Drug by Type
9.3 Central & South America Opioid Induced Constipation (OIC) Drug by Application
9.4 Central & South America Opioid Induced Constipation (OIC) Drug by Company
10 Middle East and Africa
10.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Countries
10.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Countries
10.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Type
10.3 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Application
10.4 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Company
11 Company Profiles
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.1.4 Opioid Induced Constipation (OIC) Drug Product Description
11.1.5 Recent Development
11.2 Daiichi Sankyo Co
11.2.1 Daiichi Sankyo Co Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.2.4 Opioid Induced Constipation (OIC) Drug Product Description
11.2.5 Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.3.4 Opioid Induced Constipation (OIC) Drug Product Description
11.3.5 Recent Development
11.4 Progenics Pharmaceuticals
11.4.1 Progenics Pharmaceuticals Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.4.4 Opioid Induced Constipation (OIC) Drug Product Description
11.4.5 Recent Development
11.5 Shionogi &
11.5.1 Shionogi & Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.5.4 Opioid Induced Constipation (OIC) Drug Product Description
11.5.5 Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.6.4 Opioid Induced Constipation (OIC) Drug Product Description
11.6.5 Recent Development
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.7.4 Opioid Induced Constipation (OIC) Drug Product Description
11.7.5 Recent Development
11.8 Purdue Pharma
11.8.1 Purdue Pharma Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.8.4 Opioid Induced Constipation (OIC) Drug Product Description
11.8.5 Recent Development
11.9 S.L.A. Pharma
11.9.1 S.L.A. Pharma Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.9.4 Opioid Induced Constipation (OIC) Drug Product Description
11.9.5 Recent Development
11.10 Mundipharma International Limited
11.10.1 Mundipharma International Limited Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Opioid Induced Constipation (OIC) Drug
11.10.4 Opioid Induced Constipation (OIC) Drug Product Description
11.10.5 Recent Development
11.11 Ono Pharmaceutical
11.12 Takeda Pharmaceutical Company Limited
11.13 Theravance Biopharma
11.14 Valeant Pharmaceuticals International
11.15 Cosmo Pharmaceuticals SA
11.16 Daewoong Pharmaceutical
11.17 C.B. Fleet Company
11.18 Sucampo Pharmaceuticals
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Opioid Induced Constipation (OIC) Drug Raw Material
13.1.2 Opioid Induced Constipation (OIC) Drug Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Picture of Opioid Induced Constipation (OIC) Drug
Figure Global Opioid Induced Constipation (OIC) Drug Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Opioid Induced Constipation (OIC) Drug Production Market Share by Types (Product Category) in 2017
Figure Lubiprostone Product Picture
Table Major Manufacturers of Lubiprostone
Figure Methyl Naltrexone Bromide Product Picture
Table Major Manufacturers of Methyl Naltrexone Bromide
Figure Naldemedine Product Picture
Table Major Manufacturers of Naldemedine
Figure Alvimopan Product Picture
Table Major Manufacturers of Alvimopan
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Online Pharmacies
Figure Opioid Induced Constipation (OIC) Drug Report Years Considered
Figure Global Opioid Induced Constipation (OIC) Drug Market Size 2016-2025 (Million US$)
Figure Global Opioid Induced Constipation (OIC) Drug Sales 2016-2025 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Sales by Regions 2016-2025 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions 2016-2025
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions 2016-2025
Figure 2017 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions
Table Global Opioid Induced Constipation (OIC) Drug Revenue by Regions 2016-2025 (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions 2016-2025
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions 2016-2025
Figure 2017 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions
Table Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2016-2018) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers (2016-2018)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers in 2017
Table Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2016-2018) (Million US$)
Table Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2016-2018)
Figure Opioid Induced Constipation (OIC) Drug Value Share by Manufacturers in 2017
Table Global Opioid Induced Constipation (OIC) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Opioid Induced Constipation (OIC) Drug Price (2016-2018) (USD/Unit)
Table Opioid Induced Constipation (OIC) Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Opioid Induced Constipation (OIC) Drug Product Category
Table Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2025) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by Type (2016-2025)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2025)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type in 2017
Table Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2016-2025) (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Revenue Share by Type (2016-2025)
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2016-2025)
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type in 2017
Table Opioid Induced Constipation (OIC) Drug Price by Type 2013-2018 (USD/Unit)
Table Global Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2025) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by Application (2016-2025)
Figure Global Sales Opioid Induced Constipation (OIC) Drug Market Share by Application (2016-2025)
Figure Global Sales Opioid Induced Constipation (OIC) Drug Market Share by Application (2016-2025)
Figure North America Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2016-2025 (K Units)
Figure North America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2016-2025 (Million US$)
Table North America Opioid Induced Constipation (OIC) Drug Sales by Countries (2016-2025) (K Units)
Table North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2016-2025)
Figure 2017 North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table North America Opioid Induced Constipation (OIC) Drug Revenue by Countries (2016-2025) (Million US$)
Table North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure United States Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure United States Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Canada Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Table North America Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2025) (K Units)
Table North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2025)
Figure 2017 North America Opioid Induced Constipation (OIC) Drug Market Share by Type
Table North America Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2025) (K Units)
Table North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2016-2025)
Figure 2017 North America Opioid Induced Constipation (OIC) Drug Market Share by Application
Table North America Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2018) (K Units)
Table North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2016-2018)
Figure North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2017
Figure Europe Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2016-2025 (K Units)
Figure Europe Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Opioid Induced Constipation (OIC) Drug Sales by Countries (2016-2025) (K Units)
Table Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Europe Opioid Induced Constipation (OIC) Drug Revenue by Countries (2016-2025) (Million US$)
Table Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure Germany Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Germany Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (K Units)
Figure France Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure France Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (K Units)
Figure UK Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure UK Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Italy Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Russia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2025) (K Units)
Table Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2025)
Figure 2017 Europe Opioid Induced Constipation (OIC) Drug Market Share by Type
Table Europe Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2025) (K Units)
Table Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2016-2025)
Figure 2017 Europe Opioid Induced Constipation (OIC) Drug Market Share by Application
Table Europe Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2018) (K Units)
Table Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2016-2018)
Figure Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2017
Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure China Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure China Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Japan Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Korea Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure India Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure India Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Australia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2025) (K Units)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Share by Type
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2025) (K Units)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Share by Application
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2018) (K Units)
Table Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2016-2018)
Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2017
Figure Central & South America Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales by Countries (2016-2025) (K Units)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Central & South America Opioid Induced Constipation (OIC) Drug Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure Brazil Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2025) (K Units)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Opioid Induced Constipation (OIC) Drug Market Share by Type
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2025) (K Units)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Opioid Induced Constipation (OIC) Drug Market Share by Application
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2018) (K Units)
Table Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2016-2018)
Figure Central & South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2017
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries
Figure GCC Countries Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Share by Type
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Share by Application
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2017
Table Ironwood Pharmaceuticals Company Details
Table Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Ironwood Pharmaceuticals Recent Development
Table Daiichi Sankyo Co Company Details
Table Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Daiichi Sankyo Co Recent Development
Table Pfizer Company Details
Table Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Progenics Pharmaceuticals Company Details
Table Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Progenics Pharmaceuticals Recent Development
Table Shionogi & Company Details
Table Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Shionogi & Recent Development
Table Allergan Company Details
Table Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Allergan Recent Development
Table Nektar Therapeutics Company Details
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Nektar Therapeutics Recent Development
Table Purdue Pharma Company Details
Table Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Purdue Pharma Recent Development
Table S.L.A. Pharma Company Details
Table S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table S.L.A. Pharma Recent Development
Table Mundipharma International Limited Company Details
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Mundipharma International Limited Recent Development
Table Ono Pharmaceutical Company Details
Table Takeda Pharmaceutical Company Limited Company Details
Table Theravance Biopharma Company Details
Table Valeant Pharmaceuticals International Company Details
Table Cosmo Pharmaceuticals SA Company Details
Table Daewoong Pharmaceutical Company Details
Table C.B. Fleet Company Company Details
Table Sucampo Pharmaceuticals Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Opioid Induced Constipation (OIC) Drug Value Chain
Table Typical Suppliers of Key Opioid Induced Constipation (OIC) Drug Raw Material
Table Opioid Induced Constipation (OIC) Drug Customers List
Table Opioid Induced Constipation (OIC) Drug Sales Channels
Table Opioid Induced Constipation (OIC) Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
